Office of Health and Constituent Affairs, Food and Drug Administration

  • FDA Issues Revised Draft Guidance on Developing New Hep C Treatments
    05-06-2016FDA has revised a draft guidance, titled Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment. The purpose of the guidanc…